Investigational tovecimig combined with paclitaxel significantly improved the response rate and progression-free survival (PFS) in patients with previously treated advanced or metastatic biliary tract ...

"The results of the APEX-Breast01 trial support TQB2102, a first-in-class HER2 biparatopic ADC, as a promising treatment option for patients with HER2-low breast cancer who have not previously ...

In the Breakfree-2 study, one death occurred due to septic pneumonia after a participant received high-dose cyclophosphamide, reported Jeffrey Cohen, MD, of the Cleveland Clinic Mellen Center.

Nearly one in 10 adults hospitalized with respiratory syncytial virus (RSV) infection died in the hospital or within 30 days of discharge, according to a CDC analysis of eight RSV seasons. Among ...

Atacicept and sibeprenlimab were granted accelerated FDA approval based on interim trial findings that showed a reduction in proteinuria in adults with IgA nephropathy. As a condition of the ...

Endovascular therapy (EVT) made promising forays into milder and later-presenting large vessel occlusion (LVO) strokes in a ...

Estrogen-only menopausal hormone therapy was associated with a slightly higher incidence of autoimmune disease compared with ...

At 6 months of age, most U.S. infants no longer had detectable levels of maternal neutralizing antibodies for measles, ...

Calley Means, a top advisor to Health Secretary Robert F. Kennedy Jr. and a chief advocate for the Make America Healthy Again ...

Nathan Fielder and Lance Oppenheim's new documentary, "You Can See Everything," tells a story of Elizabeth -- now Liz -- ...

Taking the nonhormonal dual neurokinin (NK) receptor antagonist elinzanetant (Lynkuet) at bedtime did not result in residual ...

The Congo's fast-spreading Ebola outbreak has amassed 9,704 confirmed cases and 4,687 deaths, according to the CDC. Meanwhile ...